APIs are the biologically active compounds used to create medicines. They can be derived from natural sources or synthesized using chemical methods. The complexity involved in API manufacturing, from chemical synthesis to formulation, requires adherence to stringent regulatory standards. This ensures that the APIs not only meet the quality and safety standards set forth by regulatory authorities but also fulfill the therapeutic needs of patients.
Coenzyme Q10, often abbreviated as CoQ10, is another vital compound that plays a key role in energy production within the mitochondria. It serves as a cofactor in the electron transport chain, a series of reactions that generate adenosine triphosphate (ATP), the energy currency of the cell. Besides its role in energy production, CoQ10 is also a powerful antioxidant, protecting cells from damage caused by free radicals.
pqq coq10
Light-sensitive APIs can undergo photodegradation, leading to the formation of inactive or harmful byproducts. This process is especially critical in the pharmaceutical industry, where the stability of a drug can significantly impact its efficacy and safety. Compounds such as certain antibiotics, vitamins, and chemotherapy agents fall into this category, necessitating specific measures to protect them from light during their life cycle.